by Stacey Johnson | Mar 30, 2018
Canada’s reputation for excellent science in the field of regenerative medicine can be traced back to the University of Toronto (U of T). Quite literally, Drs. James Till and Ernest McCulloch were U of T researchers when they discovered stem cells in the early 1960s....
by Stacey Johnson | Feb 23, 2018
If you follow amyotrophic lateral sclerosis (ALS) research, you may be interested to know that ALS Canada is holding a free webinar (registration link enclosed) on February 28 to explain how funds from the ALS #Icebucketchallenge from 2014 were spent. Do you remember...
by Samantha Payne | Feb 16, 2018
In many regenerative medicine strategies, we know that one strategy is usually not enough. Stimulating regeneration in any tissue is a complex, multifaceted problem involving the coordination of many biological signals. Yet what if we could deliver a therapeutic, like...
by Nicole Kuchinsky | Dec 5, 2017
One of my personal highlights from this year’s Till and McCulloch Meetings was attending the “Science for Citizens” panel (reported on in a previous post). Experts including Timothy Caulfield, patient advocate William Brock, and National Post writer Tom...
by Sowmya Viswanathan | Nov 30, 2017
The recent FDA approvals of Kymriah™ for the treatment of children and young adults with B-cell Acute Lymphoblastic Leukemia, and Yescarta™ to treat adults with certain types of non-Hodgkin lymphoma, and the unanimous endorsement by an FDA advisory committee of a gene...
by Samantha Yammine | Nov 23, 2017
With the extensive exploitation of regenerative medicine through the marketing and selling of unapproved stem cell “therapies” online, it was refreshing to hear an update about clinical trials for a legitimate stem cell therapy at the Till & McCulloch Meetings...
Comments